Authors :
Ogwuche John Igoche; Ruth Amarachi Ogbonna; Ejila Moses Onehi; Adamu Ibrahim Alhasan; Attah Peter; Inyang Nsikak Isaac
Volume/Issue :
Volume 9 - 2024, Issue 5 - May
Google Scholar :
https://tinyurl.com/yvhs9k27
Scribd :
https://tinyurl.com/mrr895yn
DOI :
https://doi.org/10.38124/ijisrt/IJISRT24MAY2401
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Introduction
Sexual and reproductive health challenges vis-à-vis
Human immunodeficiency virus/Acquired immune
deficiency syndrome, constitute a complex phenomenon in
young persons. These health complexes have been shown
to adversely affect the disclosure of their positive status,
their adherence to medications or retention in care and
overall quality of life. This study was meant to determine
the effectiveness of deliberate clinical mentoring on
retention in care, measured by the rate of interruption in
treatment and viral suppression among young persons on
anti-retroviral therapy.
Methods
This study employed a facility-based quasi-
experimental design. A multi-stage sampling technique
was used to select study participants. The three senatorial
zones of Nasarawa state were selected through a purposive
sampling method at stage one. One Local Government
Area was selected from each of the three senatorial zones
through simple random sampling technique at stage two.
Five health care facilities were randomly selected from
each of the three selected Local Government Areas
through balloting at stage three. Baseline data was
collected at the beginning of the study; mid-term data mid-
way into the study and post-intervention data was
collected at the end of the study. The respondents/mentees
were mentored for a period of eight months.
Results
Difference in means of interruption in treatment rates
at baseline and at midterm, which is an estimate of the
amount by which intervention changed the outcome was –
0.69605 with a p-value of 0.359. Mean differences in
interruption in treatment rates pre- and post-intervention
was 0.7333 with a p-value of 0.033, which was statistically
significant. In a similar vein, mean differences in viral
suppression rates at start of study and mid-term on the
one hand, and then pre- and post-intervention on the other
hand, were respectively 4.80000 and 3.40000. The
corresponding p-values were 0.235 and 0.174, which were
not statistically significant.
Conclusion
This study showed 100% retention among young
persons on anti-retroviral therapy following 8 months of
meticulous outreach clinical mentoring. The study also
showed improvements in viral suppression rates, but the
extent statistically, was not significant. Clinical mentoring
should therefore, be prioritized and strengthened for
better clinical care outcomes in positive young persons on
anti retroviral therapy.
Keywords :
Clinical Mentoring, Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, Interruption in Treatment, Viral Load, Young Persons.
References :
- UNAIDS. UNAIDS Data 2017. Available from: www.unaids.org/en/resources/documents/2017/2017_data_book
- Bartlett JG. Ten Years of HAART: Foundation for the Future. Available from: https://www.medscape.org/viewarticle/523119.
- Palmisano L, Vella S: A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-48. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21430338.
- Nigeria FGO. National HIV and AIDS Strategic Plan 2017-2021. 2017.
- WHO. Strengthening the adolescent component of HIV/AIDS and reproductive health programmes: a training course for public health managers. Geneva2011.
- Sobze MS, Tiotsia AT, Dongho GB, Tankui GA, Fokam J, Tsi KA, et al. Youth Awareness on Sexually Transmitted Infections, HIV and AIDS in Secondary Schools in the Dschang Municipality (Cameroon): The Mobile Caravan Project. J Public Health Afr. 2016;7(2):614.Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299163.
- WHO. Regional Atlas on Adolescent and Youth Health - the Health Status and Trend of Adolescent and Youth in Africa. . Brazzaville World Health Organisation 2017.
- Morris JL, Hamid R. Adolescent sexual and reproductive health: The global challenges. International Journal of Gynecology & Obstetrics. 2015;131(S1):S40-S42.Available from: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1016/j.ijgo.2015.02.006.
- Esther AE, Prisca Z, Ayuba IZ. Sexual and Reproductive health challenges of Adolescent males and females in some communities of Plateau State, Nigeria. International Journal of Psychology and Behavioural Sciences. 2017;7(2):55-60.
- Rachel CV, Brittany MM, Sonia L. Mental health challenges among adolescents living with HIV. Journal of the International AIDS Society. 2017;20(S3):21497.Available from: https://onlinelibrary.wiley.com/doi/abs/10.7448/IAS.20.4.21497.
- Arrive E, Dicko F, Amghar H, Aka AE, Dior H, Bouah B, et al. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One. 2012;7(3):e33690.Available from: http://www.ncbi.nlm.nih.gov/pubmed/22457782.
- Nöstlinger C, Bakeera-Kitaka S, Buyze J, Loos J, Buvé A. Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa. AIDS care. 2015;27(sup1):36-46.Available from: https://doi.org/10.1080/09540121.2015.1051501.
- Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc. 2013;16:1-19.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782478.
- Laughton B, Cornell M, Boivin M, Van Rie A. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc. 2013;16:18603.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782482.
- Bhimma R, Purswani MU, Kala U. Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc. 2013;16:18596.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782479.
- Lucien DD, Chloé GL, Chloe AT, Lorna R, Marcel Y, Sophie D, et al. Transition from paediatric to adult care of adolescents living with HIV in sub‐Saharan Africa: challenges, youth‐friendly models, and outcomes. Journal of the International AIDS Society. 2017;20(S3):34-49.Available from: https://onlinelibrary.wiley.com/doi/abs/10.7448/IAS.20.4.21528.
- Slogrove AL, Schomaker M, Davies MA, Williams P. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med.
- UNAIDS. AID SInfo 2022 [Available from: aidsinfo.unaids.org]
- UNAIDS. AIDS Info 2018 [Available from: aidsinfo.unaids.org]
- Ihvnigeria.org>nasarawa-state-surge project.org
- www.blueprint.ng>hiv-aids-nasaca
- McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of HAART in low and middle-income countries: a systematic review. Bull World Health Organ 2013; 91 : 377-85.
- Boender TS, Sigaloff KCE, McMahon JH. Long-term virological outcomes of first-line ART for HIV-1 in low and middle-income countries: a systematic review and meta analysis. Clin Infect Dis 2015; 61: 1453-61.
- Taiwo BO, Idoko JA, Welty LJ. Assessing the virologic and adherence benefits patient-selected HIV treatment partners in a resource-limited setting. JAIDS J Acquir Immune DeficSyndr 2010; 54: 85-92.
- Abah IO, Darin MK, Ebonyi AO. Patterns and predictors of first-line ART modifications in HIV-1-infected adults in a large urban outpatient cohort in Nigeria. J Int Assoc Provide AIDS Care 2015; 14(4): 348-54.
- Agbaji OO, Abah IO, Falang KD. Treatment discontinuation in adult HIV-infected patients on first-line ART in Nigeria. Curr HIV Res 2015; 13: 184-92.
- UNAIDS. 90-90-90 - An Ambitious Treatment Target to Help End the Aids Epidemic. Geneva: UNAIDS 2017.
- World Health Organisation. Supervisory Checklist for the Monitoring/Supervision of IMCI activities. Geneva:WHO; 2005. Available from www.emro.who.int/cah/pdf/pak-supervisory checklist.pdf.]
- Deress T, Jemal M, Girma M, Adane K. Knowledge, attitude and practice of waste handlers about medical waste management in Debre Markos town health care facilities, northwest Ethiopia. BMC Res Notes, 2019;12:146-151.
- Dalson K, Moses RK, Asiphas O, Florence M, Dathan M. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. Journal of the International AIDS Society 2017, 20(Suppl 4):21673
- Boyd MA, Fwoloshi S, Minchella PA, Simpungwe J, Siansalama T, Barradas DT, et al. National HIV clinical mentorship program: Enabling Zambia to accelerate control of the HIV epidemic. PLOS Glob Public Health 2022; 2(2) e0000074. https://doi.org/10.1371/journal.pgph.0000074
Introduction
Sexual and reproductive health challenges vis-à-vis
Human immunodeficiency virus/Acquired immune
deficiency syndrome, constitute a complex phenomenon in
young persons. These health complexes have been shown
to adversely affect the disclosure of their positive status,
their adherence to medications or retention in care and
overall quality of life. This study was meant to determine
the effectiveness of deliberate clinical mentoring on
retention in care, measured by the rate of interruption in
treatment and viral suppression among young persons on
anti-retroviral therapy.
Methods
This study employed a facility-based quasi-
experimental design. A multi-stage sampling technique
was used to select study participants. The three senatorial
zones of Nasarawa state were selected through a purposive
sampling method at stage one. One Local Government
Area was selected from each of the three senatorial zones
through simple random sampling technique at stage two.
Five health care facilities were randomly selected from
each of the three selected Local Government Areas
through balloting at stage three. Baseline data was
collected at the beginning of the study; mid-term data mid-
way into the study and post-intervention data was
collected at the end of the study. The respondents/mentees
were mentored for a period of eight months.
Results
Difference in means of interruption in treatment rates
at baseline and at midterm, which is an estimate of the
amount by which intervention changed the outcome was –
0.69605 with a p-value of 0.359. Mean differences in
interruption in treatment rates pre- and post-intervention
was 0.7333 with a p-value of 0.033, which was statistically
significant. In a similar vein, mean differences in viral
suppression rates at start of study and mid-term on the
one hand, and then pre- and post-intervention on the other
hand, were respectively 4.80000 and 3.40000. The
corresponding p-values were 0.235 and 0.174, which were
not statistically significant.
Conclusion
This study showed 100% retention among young
persons on anti-retroviral therapy following 8 months of
meticulous outreach clinical mentoring. The study also
showed improvements in viral suppression rates, but the
extent statistically, was not significant. Clinical mentoring
should therefore, be prioritized and strengthened for
better clinical care outcomes in positive young persons on
anti retroviral therapy.
Keywords :
Clinical Mentoring, Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, Interruption in Treatment, Viral Load, Young Persons.